MACKENZIE FINANCIAL CORP - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2020$125,000
+71.2%
39,9000.0%0.00%
Q2 2020$73,000
+82.5%
39,9000.0%0.00%
Q1 2020$40,000
-64.0%
39,9000.0%0.00%
Q4 2019$111,000
+82.0%
39,9000.0%0.00%
Q3 2019$61,000
-26.5%
39,9000.0%0.00%
Q2 2019$83,000
-42.0%
39,9000.0%0.00%
Q1 2019$143,000
-6.5%
39,9000.0%0.00%
Q4 2018$153,000
-59.4%
39,9000.0%0.00%
-100.0%
Q3 2018$377,000
+29.6%
39,9000.0%0.00%0.0%
Q2 2018$291,000
+45.5%
39,9000.0%0.00%0.0%
Q1 2018$200,000
-0.5%
39,9000.0%0.00%
Q4 2017$201,000
-18.6%
39,9000.0%0.00%
-100.0%
Q3 2017$247,000
+71.5%
39,9000.0%0.00%0.0%
Q2 2017$144,000
+10.8%
39,9000.0%0.00%0.0%
Q1 2017$130,000
+32.7%
39,9000.0%0.00%0.0%
Q4 2016$98,000
-28.5%
39,9000.0%0.00%0.0%
Q3 2016$137,000
-1.4%
39,9000.0%0.00%0.0%
Q2 2016$139,000
-15.8%
39,9000.0%0.00%0.0%
Q1 2016$165,000
-7.3%
39,9000.0%0.00%0.0%
Q4 2015$178,000
-26.7%
39,9000.0%0.00%0.0%
Q3 2015$243,00039,9000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Two Seas Capital LP 825,569$3,211,0002.46%
GREAT POINT PARTNERS LLC 668,907$2,602,0000.58%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 270,000$1,050,0000.47%
QCM Cayman, Ltd. 10,205$40,0000.24%
Pitti Group Wealth Management, LLC 50,000$195,0000.22%
RTW INVESTMENTS, LP 2,504,493$9,742,0000.14%
Hudson Bay Capital Management LP 1,805,700$7,024,0000.07%
Quinn Opportunity Partners LLC 276,485$1,076,0000.07%
Kepos Capital LP 200,000$778,0000.06%
XTX Topco Ltd 29,026$113,0000.06%
View complete list of ARBUTUS BIOPHARMA CORP shareholders